目的 比較更昔洛韋聯(lián)合甲潑尼龍綜合療法和甲潑尼龍綜合療法治療病毒性視神經(jīng)炎的療效。 方法 將2008年10月-2010年3月入院41例(60只眼)病毒抗體檢測(cè)陽(yáng)性的病毒性視神經(jīng)炎患者隨機(jī)分為治療組,21例30只眼)和對(duì)照組(20例30只眼)。于治療前和治療第3、7、14、30、90、180天觀察兩組患者的視力、視野。 結(jié)果 兩組患者的視力、平均視野缺損治療組采用更昔洛韋聯(lián)合甲潑尼龍綜合療法,對(duì)照組采用甲潑尼龍綜合療法。均隨時(shí)間得到改善(P<0.001)。兩組患者視力在治療的第3天開始恢復(fù),30 d治療組視力明顯優(yōu)于對(duì)照組(P<0.05),治療180 d時(shí)兩組視力改善無(wú)差異(P>0.05);治療組與對(duì)照組分別在第7天和第14天平均視野缺損開始恢復(fù)(P<0.001)。 結(jié)論 更昔洛韋聯(lián)合甲潑尼龍綜合療法較單純甲潑尼龍綜合療法治療病毒性視神經(jīng)炎能更快提高患者視力、恢復(fù)視野、改善患者視覺質(zhì)量。
引用本文: 李迎春,樊映川,胡建斌,陳豫川,劉婭莉,李宇. 更昔洛韋聯(lián)合甲潑尼龍治療病毒性視神經(jīng)炎. 華西醫(yī)學(xué), 2012, 27(7): 1054-1056. doi: 復(fù)制
1. | BeckRW, Probe JD. What we have 1earned from the optic neuritis treatment trail[J]. Ophthalmology, 1995, 102(10): 1504-1508. |
2. | 陳貽言.甲潑尼松龍聯(lián)合施普善治療急性視神經(jīng)炎療效觀察[J].國(guó)際眼科雜志, 2004, 4(3): 576-577. |
3. | Martin C, EnbomM, SoderstromM, et al. Absence of seven human herpesviruses,including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis[J]. Acta Neurol Scand, 1997, 95(5): 280-283. |
4. | Corssmit EP, Leverstein-van Hall MA, Portegies P, et al. Severe neurological complications in association with Epstein-Barr virus infection[J]. Neurovirol, 1997, 3(6): 460-464. |
5. | 蔡莉, 王雨生, 胡丹. 視神經(jīng)炎98例病因?qū)W臨床分析[J]. 國(guó)際眼科雜志, 2007, 7(3): 734-735. |
6. | 韋企平, 孫艷紅, 宮曉紅, 等. 兒童視神經(jīng)炎83例的病因和預(yù)后[J].國(guó)際眼科雜志, 2005, 5(1): 123-125. |
7. | Roelandt V, Fayol L, Hugonenq C, et al. Retrobulbar optic nerritis and chicken pox: a case report in a child[J]. Arch Pediatr, 2005, 12(3): 278-280. |
8. | Pless ML. Malik SI. Relapsing-remitting, corticosteroid-sensitive, varicella zoster virus optic neuritis[J]. Pediatric Neurology, 2003, 29(5): 422-424. |
9. | Mechai F, Boutolleau D, Manceron V, et al. Human herpesvirus 6-associated retrobulbar optic neuritis in an HIV-infected patient: response to anti-herpesvirus therapy and long-term outcome[J]. Medical Virol, 2007, 79(7): 931-934. |
10. | de Almeida JR, Al Khabori M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis[J]. JAMA, 2009, 302(9): 985-993. |
11. | Beck RW, Cleary PA, Anderson MM, et al. A randomized controlled trial of corticosteroids in the treatment of acute optic neuritis[J]. N Engl J Med, 1992, 326(9): 581-588. |
12. | Nikoskelainen E, Salmi A, Nikoskelainen J, et al. Virus antibody levels in serumandcerebros pinalfluids pecimens from patients with optic neuritis[J]. Acta Neurol Scand, 1977, 63(Suppl): 193-198. |
13. | Martin C, Enbom M, Soderstrom M, et al. Absence of seven humanher pesviruses,including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis[J]. Acta Neurol Scand, 1997, 95(5): 280-283. |
14. | 藍(lán)育青, 張馳, 夏朝霞, 等. 急性視神經(jīng)炎的臨床特征和療效分析[J]. 國(guó)際眼科雜志, 2008, 8(9): 1935-1937. |
15. | Potter NT, Bigazzi PE. Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein[J]. Invest Ophthalmol Vis Sci , 1992, 33: 1717-1722. |
16. | 嚴(yán)密. 關(guān)于視神經(jīng)炎治療的新概念[J]. 中華眼底病雜志, 2000, 16(2): 129. |
17. | de Almeida JR, Al Khabori M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis[J]. JAMA, 2009, 302(9): 985-993. |
18. | 金義翠. 新一代抗病毒藥物法昔洛韋[J]. 廣州醫(yī)藥, 2002, 33(6): 6. |
19. | 姜宏, 李保院, 韓業(yè)坤, 等. 更昔洛韋的臨床應(yīng)用進(jìn)展 [J]. 齊魯藥事, 2006, 25(3): 166-168. |
- 1. BeckRW, Probe JD. What we have 1earned from the optic neuritis treatment trail[J]. Ophthalmology, 1995, 102(10): 1504-1508.
- 2. 陳貽言.甲潑尼松龍聯(lián)合施普善治療急性視神經(jīng)炎療效觀察[J].國(guó)際眼科雜志, 2004, 4(3): 576-577.
- 3. Martin C, EnbomM, SoderstromM, et al. Absence of seven human herpesviruses,including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis[J]. Acta Neurol Scand, 1997, 95(5): 280-283.
- 4. Corssmit EP, Leverstein-van Hall MA, Portegies P, et al. Severe neurological complications in association with Epstein-Barr virus infection[J]. Neurovirol, 1997, 3(6): 460-464.
- 5. 蔡莉, 王雨生, 胡丹. 視神經(jīng)炎98例病因?qū)W臨床分析[J]. 國(guó)際眼科雜志, 2007, 7(3): 734-735.
- 6. 韋企平, 孫艷紅, 宮曉紅, 等. 兒童視神經(jīng)炎83例的病因和預(yù)后[J].國(guó)際眼科雜志, 2005, 5(1): 123-125.
- 7. Roelandt V, Fayol L, Hugonenq C, et al. Retrobulbar optic nerritis and chicken pox: a case report in a child[J]. Arch Pediatr, 2005, 12(3): 278-280.
- 8. Pless ML. Malik SI. Relapsing-remitting, corticosteroid-sensitive, varicella zoster virus optic neuritis[J]. Pediatric Neurology, 2003, 29(5): 422-424.
- 9. Mechai F, Boutolleau D, Manceron V, et al. Human herpesvirus 6-associated retrobulbar optic neuritis in an HIV-infected patient: response to anti-herpesvirus therapy and long-term outcome[J]. Medical Virol, 2007, 79(7): 931-934.
- 10. de Almeida JR, Al Khabori M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis[J]. JAMA, 2009, 302(9): 985-993.
- 11. Beck RW, Cleary PA, Anderson MM, et al. A randomized controlled trial of corticosteroids in the treatment of acute optic neuritis[J]. N Engl J Med, 1992, 326(9): 581-588.
- 12. Nikoskelainen E, Salmi A, Nikoskelainen J, et al. Virus antibody levels in serumandcerebros pinalfluids pecimens from patients with optic neuritis[J]. Acta Neurol Scand, 1977, 63(Suppl): 193-198.
- 13. Martin C, Enbom M, Soderstrom M, et al. Absence of seven humanher pesviruses,including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis[J]. Acta Neurol Scand, 1997, 95(5): 280-283.
- 14. 藍(lán)育青, 張馳, 夏朝霞, 等. 急性視神經(jīng)炎的臨床特征和療效分析[J]. 國(guó)際眼科雜志, 2008, 8(9): 1935-1937.
- 15. Potter NT, Bigazzi PE. Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein[J]. Invest Ophthalmol Vis Sci , 1992, 33: 1717-1722.
- 16. 嚴(yán)密. 關(guān)于視神經(jīng)炎治療的新概念[J]. 中華眼底病雜志, 2000, 16(2): 129.
- 17. de Almeida JR, Al Khabori M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis[J]. JAMA, 2009, 302(9): 985-993.
- 18. 金義翠. 新一代抗病毒藥物法昔洛韋[J]. 廣州醫(yī)藥, 2002, 33(6): 6.
- 19. 姜宏, 李保院, 韓業(yè)坤, 等. 更昔洛韋的臨床應(yīng)用進(jìn)展 [J]. 齊魯藥事, 2006, 25(3): 166-168.